Literature DB >> 17483722

Early lymphocyte recovery in Ewing sarcoma.

Steven G DuBois, Kelly Elterman, Holcombe E Grier.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17483722     DOI： 10.1097/MPH.0b013e3180590627

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN： 1077-4114            Impact factor:   1.289


× No keyword cloud information.
  6 in total

1.  Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia.

Authors:  Karen R Rabin; M Monica Gramatges; Michael J Borowitz; Shana L Palla; Xiaodong Shi; Judith F Margolin; Patrick A Zweidler-McKay
Journal:  Pediatr Blood Cancer       Date:  2011-11-18       Impact factor: 3.167

2.  Murine rhabdomyosarcoma is immunogenic and responsive to T-cell-based immunotherapy.

Authors:  Joanna L Meadors; Yonghzi Cui; Qing-Rong Chen; Young K Song; Javed Khan; Glenn Merlino; Maria Tsokos; Rimas J Orentas; Crystal L Mackall
Journal:  Pediatr Blood Cancer       Date:  2011-04-01       Impact factor: 3.167

3.  Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas.

Authors:  Melinda S Merchant; Donna Bernstein; Martha Amoako; Kristin Baird; Thomas A Fleisher; Michel Morre; Seth M Steinberg; Marianna Sabatino; Dave F Stroncek; Aradhana M Venkatasan; Bradford J Wood; Matthew Wright; Hua Zhang; Crystal L Mackall
Journal:  Clin Cancer Res       Date:  2016-01-28       Impact factor: 12.531

4.  Prospective Trial of Neutrophil/Lymphocyte Ratio and Other Blood Counts as Biomarkers of Survival among Patients with High-Grade Soft Tissue Sarcomas Treated with Pegylated Liposomal Doxorubicin and Ifosfamide.

Authors:  Keith M Skubitz; Evidio Domingo-Musibay; Bruce R Lindgren; Edward Y Cheng
Journal:  Cancers (Basel)       Date:  2022-07-14       Impact factor: 6.575

5.  A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma.

Authors:  Peter M Anderson; Stefan S Bielack; Richard G Gorlick; Keith Skubitz; Najat C Daw; Cynthia E Herzog; Odd R Monge; Alvaro Lassaletta; Erica Boldrini; Zsuzanna Pápai; Joseph Rubino; Kumudu Pathiraja; Darcy A Hille; Mark Ayers; Siu-Long Yao; Michael Nebozhyn; Brian Lu; David Mauro
Journal:  Pediatr Blood Cancer       Date:  2016-06-30       Impact factor: 3.167

Review 6.  Glutamine for Amelioration of Radiation and Chemotherapy Associated Mucositis during Cancer Therapy.

Authors:  Peter M Anderson; Rajesh V Lalla
Journal:  Nutrients       Date:  2020-06-04       Impact factor: 5.717
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.